Barclays analyst Adrienne Yih upgraded National Vision (EYE) to Overweight from Equal Weight with a price target of $30, up from $17. The firm has a positive view on the company’s transformation efforts. It expects National Vision’s customer focus to dive growth in its total addressable market and ticket. Further, the company should experience wider optometrist reach via remote exams and improved hiring and it has low tariff exposure, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EYE:
- National Vision Holdings Elects Directors at Annual Meeting
- National Vision price target raised to $26 from $22 at BofA
- Strategic Growth Potential and Competitive Advantage Drive Buy Rating for National Vision Holdings
- National Vision price target raised to $19 from $13 at BMO Capital
- National Vision Holdings: Balancing Optimism and Caution Amid Mixed Recovery